Cantor Fitzgerald Comments on Centene FY2025 Earnings

Centene Corporation (NYSE:CNC) – Equities researchers at Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for shares of Centene in a note issued to investors on Thursday, October 30th. Cantor Fitzgerald analyst S. James now forecasts that the company will post earnings of $2.02 per share for the year, up from their previous estimate of $1.71. Cantor Fitzgerald currently has a “Neutral” rating and a $41.00 price target on the stock. The consensus estimate for Centene’s current full-year earnings is $6.86 per share. Cantor Fitzgerald also issued estimates for Centene’s FY2026 earnings at $2.83 EPS.

Centene (NYSE:CNC) last announced its earnings results on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The business had revenue of $49.69 billion for the quarter, compared to analyst estimates of $47.50 billion. During the same period last year, the firm posted $1.62 earnings per share. The company’s revenue for the quarter was up 18.2% compared to the same quarter last year.

A number of other analysts also recently commented on CNC. Sanford C. Bernstein restated an “outperform” rating on shares of Centene in a report on Wednesday. Barclays boosted their target price on shares of Centene from $33.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Friday, September 12th. Wall Street Zen downgraded Centene from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Cowen reissued a “hold” rating on shares of Centene in a report on Friday. Finally, UBS Group set a $42.00 target price on Centene and gave the stock a “neutral” rating in a research report on Thursday. Three analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $40.53.

Centene Stock Performance

Shares of CNC stock opened at $35.34 on Monday. The company has a current ratio of 1.08, a quick ratio of 1.10 and a debt-to-equity ratio of 0.83. Centene has a 12-month low of $25.08 and a 12-month high of $66.81. The company has a market cap of $17.37 billion, a price-to-earnings ratio of -3.27, a price-to-earnings-growth ratio of 1.24 and a beta of 0.48. The stock has a 50 day simple moving average of $33.57 and a 200-day simple moving average of $41.44.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of CNC. Vanguard Group Inc. boosted its holdings in shares of Centene by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 58,396,605 shares of the company’s stock worth $3,169,768,000 after acquiring an additional 869,706 shares in the last quarter. Norges Bank bought a new position in Centene in the second quarter valued at about $1,435,997,000. State Street Corp lifted its position in Centene by 2.3% during the 2nd quarter. State Street Corp now owns 23,186,927 shares of the company’s stock valued at $1,258,586,000 after purchasing an additional 514,600 shares during the period. Geode Capital Management LLC grew its holdings in Centene by 2.2% during the 2nd quarter. Geode Capital Management LLC now owns 13,208,639 shares of the company’s stock worth $718,547,000 after acquiring an additional 279,637 shares during the period. Finally, Invesco Ltd. grew its stake in shares of Centene by 5.7% during the second quarter. Invesco Ltd. now owns 11,725,910 shares of the company’s stock worth $636,482,000 after purchasing an additional 633,946 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.

Insider Transactions at Centene

In other Centene news, CEO Sarah London acquired 19,230 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was purchased at an average cost of $25.50 per share, for a total transaction of $490,365.00. Following the transaction, the chief executive officer owned 845,275 shares of the company’s stock, valued at $21,554,512.50. The trade was a 2.33% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.36% of the company’s stock.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.